PR-b-targeted PEGylated liposomes for prostate cancer therapy

Langmuir

Volumn 24, Issue 23, 2008, Pages 13518-13524

  Demirgöz, Döne ^a   Garg, Ashish ^a   Kokkoli, Efrosini ^a  

^a University of Minnesota   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICINCHONINIC ACIDS; BINDING SEQUENCES; CELL BINDINGS; DELIVERY SYSTEMS; FUNCTIONALIZATION; FUNCTIONALIZED; HUMAN PROSTATE CANCER CELLS; HYDROPHOBIC TAILS; INTEGRINS; LIPOSOMAL FORMULATIONS; NATIVE PROTEINS; NATURAL LIGANDS; PEGYLATED LIPOSOMES; POLY(ETHYLENE GLYCOL); PRIMARY BINDING SITES; PROSTATE CANCER CELLS; PROSTATE CANCERS; PROTEIN ASSAYS; RGD PEPTIDES; STEALTH LIPOSOMES; SURFACE LIGANDS; TARGETED DELIVERIES; TUMOR NECROSIS FACTORS;

AMINES; BINDING ENERGY; BIOMIMETICS; CELLS; ETHYLENE; ETHYLENE GLYCOL; GLYCOPROTEINS; LIGANDS; LIPOSOMES; PHOSPHOLIPIDS; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES;

BINDING SITES;

FIBRONECTIN; LIGAND; LIPOSOME; MACROGOL DERIVATIVE; NANOPARTICLE; OLIGOPEPTIDE; TUMOR NECROSIS FACTOR ALPHA; VERY LATE ACTIVATION ANTIGEN 5;

APOPTOSIS; ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG SCREENING; FLOW CYTOMETRY; HUMAN; MALE; METABOLISM; MOLECULAR MIMICRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROSTATE TUMOR; SURFACE PROPERTY; TUMOR CELL CULTURE;

APOPTOSIS; BINDING SITES; DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG SCREENING ASSAYS, ANTITUMOR; FIBRONECTINS; FLOW CYTOMETRY; HUMANS; INTEGRIN ALPHA5BETA1; LIGANDS; LIPOSOMES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MOLECULAR MIMICRY; MOLECULAR STRUCTURE; NANOPARTICLES; OLIGOPEPTIDES; POLYETHYLENE GLYCOLS; PROSTATIC NEOPLASMS; SURFACE PROPERTIES; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 62649127577     PISSN: 07437463     EISSN: None     Source Type: Journal    
DOI: 10.1021/la801961r     Document Type: Article

References (54)

1. Torchilin, V. P. Eur. J. Pharm. Sci. 2000, 11, S81-S91.
2. Ranney, D. F. Biochem. Pharmacol. 2000, 59, 105-114.
3. Varner, J. A.; Cheresh, D. A. Curr. Opin. Cell Biol. 1996, 8, 724-730.
4. Davison, E.; Diaz, R. M.; Hart, I. R.; Santis, G.; Marshall, J. F. J. Virol. 1997, 71, 6204-6207.
5. Matter, M. L.; Zhang, Z.; Nordstedt, C.; Ruoslahti, E. J. Cell Biol. 1998, 141, 1019-1030.
6. Livant, D. L.; Brabec, R. K.; Kurachi, K.; Allen, D. L.; Wu, Y.; Haaseth, R.; rews, P.; Ethier, S. P.; Markwart, S. J. Clin. Invest. 2000, 105, 1537-1545.
7. van Golen, K. L.; Bao, L. W.; Brewer, G. J.; Pienta, K. L.; Kamradt, J. M.; Livant, D. L.; Merajver, S. D. Neoplasia 2002, 4, 373-379.
8. Kim, S.; Bell, K.; Mousa, S. A.; Varner, J. Am. J. Path. 2000, 156, 1345-1362.
9. Gong, J.; Wang, D.; Sun, L.; Zborowska, E.; Willson, J. K.; Brattain, M. G. Cell Growth Differ. 1997, 8, 83-90.
10. Jayne, D. G.; Heath, R. M.; Dewhurst, O.; Scott, N.; Guillou, P. J. Eur. J. Surg. Oncol. 2002, 28, 30-36.
11. Ellis, L. M. Am. Surg. 2003, 69, 3-10.
12. Jia, Y. F.; Zeng, Z.-Z.; Markwart, S. M.; Rockwood, K. F.; Ignatoski, K. M. W.; Ethier, S. P.; Livant, D. L. Cancer Res. 2004, 64, 8674-8681.
13. Chen, J. H.; De, S.; Brainard, J.; Byzova, T. V. Cell Commun. Adhes. 2004, 11, 1-11.
14. Livant, D. L.; Brabec, R. K.; Pienta, K. J.; Allen, D. L.; Kurachi, K.; Markwart, S.; Upadhyaya, A. Cancer Res. 2000, 60, 309-320.
15. White, E. S.; Livant, D. L.; Markwart, S.; Arenberg, D. A. J. Immunol. 2001, 167, 5362-5366.
16. Stoeltzing, O.; Liu, W. B.; Reinmuth, N.; Fan, F.; Parry, G. C.; Parikh, A. A.; McCarthy, M. F.; Corazon, D. B.; Mazar, A. P.; Ellis, L. M. Int. J. Cancer 2003, 104, 496-503.
17. Meerovitch, K.; Bergeron, F.; Leblond, L.; Grouix, B.; Poirier, C.; Bubenik, M.; Chan, L.; Gourdeau, H.; Bowlin, T.; Attardo, G. Vasc. Pharmacol. 2003, 40, 77-89.
18. Yokoyama, Y.; Ramakrishnan, S. Int. J. Cancer 2004, 111, 839-848.
19. Shannon, K. E.; Keene, J. L.; Settle, S. L.; Duffin, T. D.; Nickols, M. A.; Westlin, M.; Schroeter, S.; Ruminski, P. G.; Griggs, D. W. Clin. Exp. Metastasis 2004, 21, 129-138.
20. Oku, N.; Koike, C.; Tokudome, Y.; Okada, S.; Nishikawa, N.; Tsukada, H.; Kiso, M.; Hasegawa, A.; Fujii, H.; Murata, J.; Saiki, I. Adv. Drug Delivery Rev. 1997, 24, 215-223.
21. Kurohane, K.; Namba, Y.; Oku, N. Life Sci. 2000, 68, 273-281.
22. Schiffelers, R. M.; Molema, G.; ten Hagen, T. L. M.; Janssen, A. P. C. A.; Schraa, A. J.; Kok, R. J.; Koning, G. A.; Storm, G. J. Liposome Res. 2002, 12, 129-135.
23. Schiffelers, R. M.; Koning, G. A.; ten Hagen, T. L. M.; Fens, M. H. A. M.; Schraa, A. J.; Janssen, A. N. P. C. A.; Kok, R. J.; Molema, G.; Storm, G. J. Controlled Release 2003, 91, 115-122.
24. Koning, G. A.; Fretz, M. M.; Woroniecka, U.; Storm, G.; Krijger, G. C. Appl. Radiat. Isot. 2004, 61, 963-967.
25. Hölig, P.; Bach, M.; Völkel, T.; Nahde, T.; Hoffmann, S.; Müller, R.; Kontermann, R. E. Protein Eng., Des. Sel. 2004, 17, 433-441.
26. Dubey, P. K.; Mishra, V.; Jain, S.; Mahor, S.; Vyas, S. P. J. Drug Targeting 2004, 12, 257-264.
27. Xiong, X.-B.; Huang, Y.; Lu, W.-L.; Zhang, X.; Zhang, H.; Nagai, T.; Zhang, Q. J. Pharm. Sci. 2005, 94, 1782-1793.
28. Sofou, S. Nanomedicine 2007, 2(5), 711-724.
29. Pierschabacher, M. D.; Hayman, E. G.; Ruoslahti, E. Proc. Natl. Acad. Sci. U.S.A. 1983, 80, 1224-1227.
30. Yang, X. B.; Roach, H. I.; Clarke, N. M.; Howdle, S. M.; Quirk, R.; Shakesheff, K. M.; Oreffo, R. O. Bone 2001, 29, 523-531.
31. Akiyama, S. K.; Aota, S.; Yamada, K. M. Cell Adhes. Commun. 1995, 3, 13-25.
32. Ochsenhirt, S. E.; Kokkoli, E.; McCarthy, J. B.; Tirrell, M. Biomaterials 2006, 27(20), 3863-3874.
33. Aucoin, L.; Griffith, C. M.; Pleizier, G.; Deslandes, Y.; Sheardown, H. J. Biomater. Sci., Polym. Ed. 2002, 13, 447-462.
34. Benoit, D. S. W.; Anseth, K. S. Biomaterials 2005, 26, 5209-5220.
35. Kao, W. J. Biomaterials 1999, 20(23-24), 2213-2221.
36. Suzuki, Y.; Hojo, K.; Okazaki, I.; Kamada, H.; Sazaki, M.; Maeda, M.; Nomizu, M.; Yamamoto, Y.; Nakagawa, S.; Mayumi, T.; Kawasaki, K. Chem. Pharm. Bull. 2002, 50, 1229-1232.
37. Kim, T.-I.; Jang, J.-H.; Lee, Y.-M.; Ryu, I.-C.; Chung, C.-P.; Han, S.-B.; Choi, S.-M.; Ku, Y. Biotechnol. Lett. 2002, 24, 2029-2033.
38. Mardilovich, A.; Kokkoli, E. Langmuir 2005, 21, 7468-7475.
39. Kokkoli, E.; Mardilovich, A.; Wedekind, A.; Rexeisen, E. L.; Garg, A.; Craig, J. A. Soft Matter 2006, 2(12), 1015-1024.
40. Mardilovich, A.; Craig, J. A.; McCammon, M. Q.; Garg, A.; Kokkoli, E. Langmuir 2006, 22, 3259-3264.
41. Mardilovich, A.; Kokkoli, E. Biomacromolecules 2004, 5, 950-957.
42. Garg, A.; Tisdale, A. W.; Haidari, E.; Kokkoli, E. Int. J. Pharm.,. published online Sept 19, http://dx.doi.org/10.1016/j.ijpharm.2008. 09.016.
43. Craig, J. A.; Rexeisen, E. L.; Mardilovich, A.; Shroff, K.; Kokkoli, E. Langmuir 2008, 24(18), 10282-10292.
44. Sensibar, J. A.; Sutkowski, D. M.; Raffo, A.; Buttyan, R.; Griswold, M. D.; Sylvester, S. R.; Kozlowski, J. M.; Lee, C. Cancer Res. 1995, 55, 2431-2437.
45. Sherwood, E.; Ford, T.; Lee, C.; Kozlowski, J. J. Biol. Response Modif. 1990, 9, 44-52.
46. Fenske, D. B.; Maurer, N.; Cullis, P. R. In Liposomes, 2nd ed.; Torchilin, V. P., Weissig, V., Eds.; Oxford University Press: Oxford, 2003; pp 167-191.
47. Csaba, N.; Gonzalez, L.; Sanchez, A.; Alonso, M. J. J. Biomater. Sci., Polym. Ed. 2004, 15(9), 1137-1151.
48. Duncanson, W. J.; Figa, M. A.; Hallock, K.; Zalipsky, S.; Hamilton, J. A.; Wong, J. Y. Biomaterials 2007, 28(33), 4991-4999.
49. Chen, P. S.; Toribara, T. Y.; Warner, H. Anal. Chem. 1956, 28, 1756-1758.
50. Fiske, C. H.; Subbarow, Y. J. Biol. Chem. 1925, 66, 375-400.
51. Colin, M.; Maurice, M.; Trugnan, G.; Kornprobst, M.; Harbottle, R. P.; Knight, A.; Cooper, R. G.; Miller, A. D.; Capeau, J.; Coutelle, C.; Brahimi-Horn, M. C. Gene Ther. 2000, 7(2), 139-152.
52. Bertorelle, F.; Wilhelm, C.; Roger, J.; Gazeau, F.; Menager, C.; Cabuil, V. Langmuir 2006, 22(12), 5385-5391.
53. Richardson, S. C. W.; Wallom, K.-L.; Ferguson, E. L.; Deacon, S. P. E.; Davies, M. W.; Powell, A. J.; Piper, R. C.; Duncan, R. J. Controlled Release 2008, 127, 1-11.
54. Xiong, X. B.; Huang, Y.; Lu, W. L.; Zhang, X.; Zhang, H.; Nagai, T.; Zhang, Q. J. Controlled Release 2005, 107, 262-275.